Cite
A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)
MLA
Fält, A., et al. A Swedish Nationwide Pharmaco-Epidemiological Study of the Long-Term Safety and Effectiveness of Fingolimod (IMSE 2). 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1235202181&authtype=sso&custid=ns315887.
APA
Fält, A., Kagstrom, S., Demirbuker, S. S., Hillert, J., Nilsson, P., Dahle, C., Svenningsson, A., Lycke, J., Landtblom, A.-M., Burman, J., Martin, C., Sundström, P., Gunnarsson, M., Piehl, F., & Olsson, T. (2018). A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2).
Chicago
Fält, A., S. Kagstrom, S. Safer Demirbuker, J. Hillert, P. Nilsson, C. Dahle, A. Svenningsson, et al. 2018. “A Swedish Nationwide Pharmaco-Epidemiological Study of the Long-Term Safety and Effectiveness of Fingolimod (IMSE 2).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1235202181&authtype=sso&custid=ns315887.